AN2 Therapeutics, Inc. Public Float
AN2 Therapeutics, Inc. (ANTX) had Public Float of $23.08 million as of 2025-06-30, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-17
- 2025-06-30: Entity Public Float $23.08M.
- 2024-06-28: Entity Public Float $41.13M.
- 2023-06-30: Entity Public Float $108.67M.
- 2022-06-30: Entity Public Float $118.89M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $23.08M 10-K · filed 2026-03-17 |
| 2024-06-28 | $41.13M 10-K · filed 2025-03-25 |
| 2023-06-30 | $108.67M 10-K/A · filed 2024-05-14 |
| 2022-06-30 | $118.89M 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |